iFlash-2019-nCoV Neutralization Antibody Test

iFlash-2019-nCoV NAb (Neutralization Antibody) assay is a chemiluminescence immunoassay (CLIA) for the qualitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma.
Category
COVID-19
Product Overview

iFlash-2019-nCoV NAb (Neutralization Antibody) assay is a chemiluminescence immunoassay (CLIA) for the qualitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination.

 

Clinical Benefits:

  • Evaluate COVID-19 vaccines development and efficacy
  • Monitor the NAb titers in COVID-19 patients and vaccinated individuals. 
  • Analyze herd immunity status to guide policymakers.
  • Monitoring in during convalescent plasma therapy or other antibody related treatments.
Language
Search
亚辉龙

Join Us

关注我们

Wechat

Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Follow YHLO

wechatwechat wechat wechat wechat

© 2020  Shenzhen YHLO Biotech Co., Ltd.  All rights reserved.  粤ICP备19040167号